Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Stockholders' Deficit (Details 2)

v3.19.3
Note 6 - Stockholders' Deficit (Details 2) - USD ($)
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Allocated share-based compensation expense $ 451,000 $ 164,000
Research and Development Expense    
Allocated share-based compensation expense 54,000 15,000
General and Administrative Expense    
Allocated share-based compensation expense $ 397,000 $ 149,000